Breaking News Instant updates and real-time market news.

CYAD

Celyad

$21.35

(0.00%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55

Celyad management to meet with William Blair

Meeting to be held in Boston on March 19 hosted by William Blair.

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 09

    Apr

CYAD Celyad
$21.35

(0.00%)

07/02/18
07/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Howard Hughes (HHC) initiated with a Buy at Jefferies. 2. Celyad (CYAD) initiated with a Buy at H.C. Wainwright. 3. Veoneer (VNE) initiated with a Sector Perform at RBC Capital. 4. Melinta Therapeutics (MLNT) initiated with an Overweight at Cantor Fitzgerald. 5. Axon (AAXN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
WBLR
10/30/18
INITIATION
WBLR
Outperform
Celyad initiated with an Outperform at William Blair
William Blair analyst Raju Prasad started Celyad with an Outperform rating.
10/30/18
WBLR
10/30/18
INITIATION
WBLR
Outperform
William Blair starts Celyad with Outperform, $53 fair value estimate
William Blair analyst Raju Prasad initiated coverage of Celyad with an Outperform rating and $53 fair value estimate. Celyad's lead candidate, CYAD-01, is an autologous NKG2D chimeric antigen receptor (CAR)-T cell therapy being developed to treat both solid tumors and hematologic or liquid cancers, Prasad tells investors in a research note. The analyst believes the company's platform has several advantages, including a product profile that could be suitable for repeat injections, the ability to treat multiple tumor types using one CAR construct and the potential to show an adaptive immune response. Celyad's allogeneic platform is "significantly underappreciated," says Prasad.
11/12/18
PIPR
11/12/18
NO CHANGE
Target $51
PIPR
Overweight
Celyad price target lowered to $51 from $74 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Celyad to $51 after rolling forward his discount period to 2019. The analyst, however, keeps an Overweight rating on the shares after the company updated solid tumor data from the Think and Shrink studies of CYAD-01. Celyad will report Think data on 12 relapsed/refractory acute myeloid leukemia patients in December, Tenthoff tells investors in a research note. He also believes the company has enough cash to fund its operations through mid-2020.

TODAY'S FREE FLY STORIES

BX

Blackstone

$47.10

0.62 (1.33%)

16:34
10/13/19
10/13
16:34
10/13/19
16:34
Periodicals
Blackstone discussed with Citadel about buying stake, WSJ reports »

Blackstone has held talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

16:29
10/13/19
10/13
16:29
10/13/19
16:29
Periodicals
Google bars high-interest consumer loan services from app store, WSJ reports »

Google has barred…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

16:28
10/13/19
10/13
16:28
10/13/19
16:28
General news
Trump working with Congress on 'powerful' Turkey sanctions »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

16:23
10/13/19
10/13
16:23
10/13/19
16:23
Hot Stocks
Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies »

Allergan and Molecular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$39.49

1.8 (4.78%)

, UBER

Uber

$30.09

1.19 (4.12%)

16:04
10/13/19
10/13
16:04
10/13/19
16:04
Periodicals
Lyft sues NYC over cruising time caps, Reuters reports »

Following its rival…

LYFT

Lyft

$39.49

1.8 (4.78%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated  »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

LLY

Eli Lilly

$108.37

1.54 (1.44%)

14:15
10/13/19
10/13
14:15
10/13/19
14:15
Hot Stocks
Eli Lilly says Taltz met co-primary endpoints in Phase 3 plaque psoriasis study »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PCG

PG&E

$8.08

0.3 (3.86%)

07:46
10/13/19
10/13
07:46
10/13/19
07:46
Hot Stocks
PG&E says all customers impacted by safety shutoffs now have power »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

, VIR

Vir Biotechnology

$14.06

(0.00%)

07:18
10/13/19
10/13
07:18
10/13/19
07:18
On The Fly
Opening Day: BioNTech raises $150M in smaller than expected IPO »

BioNTech (BNTX) raised…

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

VIR

Vir Biotechnology

$14.06

(0.00%)

HBT

HBT Financial

$15.56

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

KRAT

Karat Packaging

$0.00

(0.00%)

POST

Post Holdings

$101.19

1.94 (1.95%)

IPHA

Innate Pharma

$0.00

(0.00%)

BRBR

BellRing Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 17

    Oct

  • 17

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/13/19
10/13
04:55
10/13/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

AMBA

Ambarella

$53.62

1.25 (2.39%)

, ON

ON Semiconductor

$18.74

0.67 (3.71%)

09:31
10/12/19
10/12
09:31
10/12/19
09:31
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AMBA

Ambarella

$53.62

1.25 (2.39%)

ON

ON Semiconductor

$18.74

0.67 (3.71%)

AAPL

Apple

$236.21

6.12 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

  • 30

    Oct

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

, AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

08:48
10/12/19
10/12
08:48
10/12/19
08:48
Periodicals
Bed Bath & Beyond not a bargain, Barron's says »

While Bed Bath &…

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

SNE

Sony

$58.16

0.83 (1.45%)

, MSFT

Microsoft

$139.62

0.52 (0.37%)

08:39
10/12/19
10/12
08:39
10/12/19
08:39
Periodicals
Activision, Take-Two to benefit from next videogame cycle, Barron's says »

Sony (SNE) has announced…

SNE

Sony

$58.16

0.83 (1.45%)

MSFT

Microsoft

$139.62

0.52 (0.37%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

  • 21

    Nov

K

Kellogg

$62.14

-0.27 (-0.43%)

08:27
10/12/19
10/12
08:27
10/12/19
08:27
Periodicals
Kellogg stock looking like worth 'snacking on,' Barron's says »

Kellogg's stock fell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

, ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

08:20
10/12/19
10/12
08:20
10/12/19
08:20
Periodicals
J&J, Pentair among stocks with sage, growing dividends, Barron's says »

Investors seeking yield…

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/12/19
10/12
04:55
10/12/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

THTX

Theratechnologies

$3.76

0.01 (0.27%)

18:32
10/11/19
10/11
18:32
10/11/19
18:32
Hot Stocks
Theratechnologies: Tesamorelin study results on NAFLD published in Lancet HIV »

Theratechnologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

18:26
10/11/19
10/11
18:26
10/11/19
18:26
Hot Stocks
Wendy's CEO: We are really focused on the long term »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

18:25
10/11/19
10/11
18:25
10/11/19
18:25
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

DOJ to more closely…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

BA

Boeing

$374.90

3.97 (1.07%)

18:22
10/11/19
10/11
18:22
10/11/19
18:22
Hot Stocks
Boeing board separates CEO and Chairman roles »

Boeing announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.